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7Chapter 1 
Introduction 
1.1 Purpose of Study 
Even with advances in cancer research and technology cancer is the second leading cause 
of death in the United States as no cure exists1. According to the latest America Cancer 
Society statistics2, this year alone nearly 560,000 people will die from the disease. Of the 
total 1.45 million that will be diagnosed, 218,000 will be prostate carcinoma and over 
27,000 cases will result in death2. There is, however, a strong connection between early 
detection and positive patient outlook. In the case of lung cancer there is a 70% survival 
rate for resected infected tissue in stage I carcinoma versus only 12% when the cancer is 
not detected in this stage3. Besides lung carcinoma, early detection is the best hope in all 
cancers, to improve patient survival, disease prognosis and may lead to cancer 
prevention.  
 
The major goal of this research is to develop a rapid, ultrasensitive, economic, and 
specific nanomaterial-based sensor for the early detection of cancer biomarker proteins, 
particularly Prostate Specific Antigen (PSA), in clinically relevant samples, such as 
serum and tissue lysate. In this research study, we are using vertically aligned single-
walled carbon nanotubes (SWNT) attached to conductive surfaces capable of electrical 
conduction to fabricate these ultrasensitive sandwich immuosensors. The electrical signal 
 
1 Ahmedin Jemal, Taylor Murray, Elizabeth Ward, Alicia Samuels, Ram C. Tiwari, Asma Ghafoor, Eric J.  
 Feuer, Michael J. Thun. CA Cancer J. Clin. 2005, 55(1), 10-30.
2 Estimated New Cancer Cases and Deaths by Sex for All Sites, US, 2007. American Cancer Society.   
 2007. 15 Apr. 2007 <http://www.cancer.org/downloads/stt/CFF2007EstCsDths07.pdf>. 
3 Henschke, Claudia; Dorthy I. McCauley, David F. Yankelevitz, David P Naidich, Gergeann McGuiness,  
 Olli S. Miettinen, Daniel M. Libby, Mark W. Pasmantier, June Koizumi, naser K. Altorki, James P.  
 Smith. The Lance. 1999, 354, 99-105. 
8is realized using enzyme catalytic reactions involving Horseradish Peroxidase (HRP) 
tracer in the antibody-antigen biorecognition event.   
 
This project employs SWNT with ~1.4 nm diameters and the world’s highest 
conductivity per unit mass4. We have combined efficient electrical transduction by 
shortened carbon nanotubes with biomolecular recognition by antibodies. Electronic 
devices offer elegant ways for interfacing biorecognition and transduction events and are 
uniquely qualified for meeting the high sensitivity and portability requirements of future 
biodetection systems5,6. Electrochemical bioassays involving enzyme tracers have 
received particular attention due to the intrinsic signal amplification provided by 
biocatalytic reactions. 
An important future goal of this project is to develop a protein sensor array that is capable 
of measuring a collection of cancer biomarker proteins in a single sample. This array 
would allow for lower cost per analysis and a clinically viable approach for early cancer 
detection. The onset of cancer is indicated by biomarker serum level change over time7.
These biomarkers often indicate at abnormal levels, or abnormal level changes over time, 
a disturbance in the proper regulation of a specific tissue or organ often indicating 
carcinoma8.
4 Dresselhaus, M. S.; Dresselhaus, G.; Avouris, P.; Editors, Carbon nanotubes: Synthesis, Structure,  
 Properties, and Applications. Topics Appl. Phys., 2001.
5 Palecek, E.; Fojta, M. Detecting DNA hybridization and damage. Anal. Chem. 2001, 73, 75A. 
6 Wang, J. Real-time electrochemical monitoring: toward green analytical chemistry. Acc. ChemRes.2002,
35, 811. 
7 Brosman, Stanley A. "Prostate Specific Antigen." EMedicine From WebMD. 15 June 2006. University  
 of California Los Angeles Medical School. 23 Mar. 2007 
8 Weston, A.D.; Hood, L. J. Proteome Res. 2004, 3, 179-196. 
9Currently there are many methods for detection of proteins, however all have many 
drawbacks.    DNA microarrays measure gene expression by quantifying messenger RNA 
levels. However, these mRNA levels are not indicative of protein expression8. Protein 
microarrays, specifically ELISA, are another similar method where antibodies and 
enzyme-labeled secondary antibodies are used in a sandwich immunoassay. This method 
is selective and sensitive but is limited by the required sample size and time9.
Mass spectrometry (MS) is yet another method for protein detection. This technique 
requires liquid chromatograph protein purification, proteolytic cleavage of peptide chains 
and labeling with isotopes for analysis, which is labor-intensive and expensive10. This is 
an unlikely method for mass sampling in a timely and reasonably priced manner.  
 
This innovative immunosensor design would lead to a miniaturized electrochemical 
immunosensor arrays with higher throughput and lower cost per analysis. Such a device 
would be a clinically viable approach for early cancer detection compared to expensive 
and complex MS methods. We believe that the SWNT protein microarrays offer 
unprecedented promise for early cancer diagnosis. 
 
Chapter 2 of this thesis describes peroxidase activity of horseradish peroxidase and 
myoglobin on vertically aligned carbon nanotubes; key steps in the electrochemical 
detection scheme. These initial studies were intended to establish the optimum conditions 
for the SWNT “forest” fabrication and also serve as quality control experiments to 
 
9 Wilson, D.S.; Nock, S. Angew. Chem. Int. Ed. 2003, 42, 494-500 
10 Aebersold, Ruedi; Goodlet, David. Chem. Review. 2001, 101, 269-295 
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determine the quality of our SWNT forests. Electrode-driven peroxidase activity of 
myoglobin and horseradish peroxidase attached to the carbon nanotube arrays was 
demonstrated, with detection limits for hydrogen peroxide in buffer solutions of ~100 
nM. Our results suggest that the vertically aligned nanotube arrays behave like metal 
electrical conductors shuttling electrons from the external circuit to redox active sites of 
the enzymes.  
 
Chapter 3 demonstrates our novel nanomaterial-based sensor for use in electrochemical 
detection of prostate specific antigen. We obtained a detection limit of 0.4 ng/mL, which 
compares favorably with common methods such as enzyme-linked immunosorbent assay 
(ELISA). Work is currently in progress to lower the detection limits using signal 
amplification strategies, the established optimized SWNT array fabrication protocol and 
conditions for minimal non-specific binding events.  
 
Finally, chapter 4 addresses the Pell honors program connection with this research work. 
As a Pell student, with the goal of learning to understand the importance of international 
relations and public policy, I have found through this research experience that early 
detection of cancer biomarkers is a key step towards improving cancer patient’s survival 
and may even lead to cancer prevention.  Increasing the sensitivity of the detection 
methods would indicate this early detection and therefore would be essential in lowering 
healthcare costs for cancer patients as treatments would be much less invasive and time 
consuming. Detection of high levels of PSA in serum can lead to detection of prostate 
cancer well before surgery is required, resulting in much less aggressive, more successful 
treatments that minimize patient discomfort and physiological dysfunction. 
11 
1.2 Prostate Specific Antigen 
PSA is a single chain glycoprotein from the Kallikrein family of proteolyses11. It is 
composed of a 237 amino acid chain having a molecular weight of 26kDa12. PSA has 
multiple epitopes capable of binding with monoclonal antibodies, which in this research 
is essential to its detection13. PSA is a known biomarker for the detection of prostate 
cancer8. The detection of PSA rising levels allows for a probable diagnosis of prostate 
cancer.  
 
1.3 Carbon nanotubes 
Single-Wall carbon nanotubes (SWNTs) are essentially a seamless cylinder of graphene. 
The tubes are capable of acting as conductors or semiconductors depending on the chiral 
alignment of the molecules. These one-dimensional fibers exhibit electrical conductivity 
as high as copper, thermal conductivity as high as diamond, strength 100 times greater 
than steel at one sixth the weight, and high strain to failure (high aspect ratio)14. There are 
two types of carbon nanotubes, SWNT and multi-wall carbon nanotubes (MWNT). 
MWNT  possess the properties of the SWNTs but are composed of one graphene cylinder 
inside of another.  
 
The SWNTs used in this experiment are capable of single electron conduction. At 1.4nm 
diameter SWNTs have the highest conductivity per unit mass in the world. The SWNT 
 
11 RCSB Protein Data Bank. wwwPDB. 15 Apr. 2007  
 <http://www.rcsb.org/pdb/explore.do?structureId=1GVZ>. 
12 Belanger, A; H Van Halbeek; HC Graves; K Grandbois; Ta Stamey; L Huang; I Poppe; and F Labrie.  
 Prostate 1995, 27, 187-197 
13 Leinonen, J.; Wu, P.; Stenman, U. Clinical Chemistry. 2002, 48, 2208-2216. 
14 "Nanotubes and Buckyballs." Nanotechnology Now. 15 Aug. 2006. 7 Mar. 2007 <http://www.nanotech- 
 now.com/nanotube-buckyball-sites.htm>. 
12 
used in this work are carboxyl functionalized by acid treatment and are capable of 
attachment of biological molecules by bioconjugation reactions. Due to their unique 
structural, electronic, thermal, and mechanical properties they have found wide  
 
Figure 1-1.Prostate Specific Antigen structure as determined by x-ray diffraction15.
15 RCSB Protein Data Bank. wwwPDB. 15 Apr. 2007  
 <http://www.rcsb.org/pdb/explore.do?structureId=1GVZ>. 
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Figure 1-2. Two type of carbon nanotubes, SWNT and MWNT 
 
14 
applications in various bioanalytical applications including electrochemical detection by 
cyclic voltammetry and amperometry. 
 
1.4 Horseradish Peroxidase 
 
Horseradish peroxidase (HRP) is a member of the ferroprotoporphyrin group of 
peroxidases. It is a single chain polypeptide containing a central heme group. This heme 
group is capable of catalytic oxidation reduction by hydrogen peroxide16. Peroxidases 
have been used extensively for sensitive electrochemical detection in 
immunosensing17,18,19 and DNA hybridization5,20,21. They are excellent labels for 
electrochemical immunoassays since highly active peroxidases give large catalytic 
electrochemical signals for reduction of hydrogen peroxide at low applied voltages where 
little interferences is expected22,23.
16 "Peroxidase Enzymes and Reagents." Enzyme Explorer. 2007. Sigma-Aldrich. 15 Apr. 2007  
<http://www.sigmaaldrich.com/Area_of_Interest/Biochemicals/Enzyme_Explorer/Analytical_Enzymes/Per
oxidase_Enzymes.html>. 
17 Lu, B.; Iwuoha, E. I.; Smyth, M. R.; O’Kennedy, R. Development of an amperometric immunosensor for  
 horseradish peroxidase (HRP) involving an non-diffusional osmium redox polymer co-immobilized with  
 anti-HRP antibody, Anal. Commun. 1997, 34, 21-23. 
18 Killard, A. J.; Zhang, S.; Zhao, H.; John, R.; Iwuoha, E. I.; Smyth, M. R. Anal. Chim. Acta 1999, 400,
109-119. 
19 Killard, A. J.; Micheli, L.; Grennan, K.; Franek, M.; Kolar, V.; Moscone, D.; Palchetti, I.;  
 Smyth, M. R. Anal. Chim. Acta 2001, 427, 173-180. 
20 Azek, F.; Grossiord, C.; Joannes, M.; Limoges, B.; Brossier, P. Anal. Biochem. 2000, 284, 107-113. 
21 Caruana, D. J.; Heller, A. J. Am. Chem. Soc. 1999, 121, 769-774. 
22 Ruzgas, T.; Lindgren, A.; Gorton, L.; Hecht, H.-J.; Reichelt, J.; Bilitewski, U.  in Chambers, J. Q. and  
 Bratjer-Toth, A. Eds. Electroanalytical Methods for Biological Materials, Marcel Dekker, New York,  
 2002, pp. 233-254. 
23 Guo, Y.; Guadalupe, A. R. Direct electrochemistry of horseradish peroxidase adsorbed on glassy carbon  
 electrode from organic solutions. Chem. Comm. 1997, 1437-1438. 
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Figure 1-3. Heme group of Horseradish Peroxidase24.
24 Prahl, Scott. “Structure of Heme.” 8 June 1998. Oregon Medical Laser Center. 20 April 2007.  
 <http://omlc.ogi.edu/spectra/hemoglobin/hemestruct/index.html>. 
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Chapter 2 
 
Peroxidase Activity of Horseradish Peroxidase and Myoglobin 
on Vertically Aligned Carbon Nanotubes 
2.1. Abstract 
 
2.2. Introduction 
 
Arrays of highly conducting single-wall carbon nanotubes (SWNTs) could be uniquely 
suited for bioanalytical applications by coupling sensing biomolecules to the carboxyl-
terminated ends25,26 of the nanotubes. There are a number of established methods for 
assembling 20-100nm vertically aligned carbon nanotube arrays on surfaces in nm-scale 
bundles called SWNT forests i.e., dense orthogonally oriented arrays of shortened 
SWNTs, onto various solid substrates 27, 28, 29. In agreement with our first major goal in 
this research work to optimize the SWNT forest assembly, and biomolecular 
bioconjugation, we herein demonstrate successful fabrication of vertically aligned SWNT 
arrays. Furthermore, we show that the untethered ends of these stable SWNT forests can 
be linked to electrochemically active heme proteins through traditional bioconjugate 
chemistry to give electrochemical signatures of enzyme activity. In this work, we clearly 
show that myoglobin and horseradish peroxidase covalently linked to the SWNT forests 
exhibit quasi-reversible FeIII/FeII voltammetry and sensitive responses to H2O2. The 
unidimensional nature, high conductivity, and structural robustness of carbon nanotubes 
 
25 Liu, Jie; Andrew G. Rinzler, Hongjie Dai, Jason H. Hafner, R. Kelley Bradley, Peter J. Boul, Adrian Lu,  
 Terry Iverson, Konstantin Shelimov, Chad B. Huffman, Fernando Rodriguez-Macias, Young-Seok  
 Shon, T. Randall Lee, Daniel T. Colbert, and Richard E. Smalley Science 1998, 280, 1253 
26 Hamon, M.A.; H. Hu, P. Bhowmik, S. Niyogi, B. Zhao, M. E. Itkis, R. C. Haddon Chem. Phys. Lett.  
 2001, 347, 8. 
27 D. Chattopadhyay, I. Galeska and F. Papadimitrakopoulos; J Am. Chem. Soc. 2001, 123, 9451. 
28 Gooding, J; W. Rahmat, J. Q. Liu, W. R. Yang, D. Losic, S. Orbons, F. J. Mearns, J. G. Shapter, D. B.  
 Hibbert. J Am. Chem. Soc. 2003, 125, 9006. 
29 Patolsky, F.; Y. Weizmann, I. Willner, Chem. Int. Edition 
2004, 43, 2113 
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promise important future applications for nanosensors. Unique electrochemistry of 
soluble molecules and adsorbed proteins on cast flat non-oriented layers of single of 
multi-walled carbon nanotubes has been demonstrated30,31. It has been speculated that the 
similarity between size scales of enzymes and chemically shortened, nanoscale diameter 
SWNTs might promote the likelihood of SWNTs being able to intimately interact and be 
within electron tunneling distance of enzyme redox sites32.
2.3. Experimental Section 
 
Single-wall carbon nanotubes (HiPco, from Tubes@ rice) were carboxyl functionalized 
and shortened by sonication in a mixture of 3:1 HNO3 and H2SO4 for 4 h at 70ºC27.
Monolayers of vertically aligned, shortened SWNTs were assembled on ordinary 
pyrolytic graphite (PG) electrodes from DMF dispersions onto an underlying composite 
bed of Nafion ionomer and Fe3+-precipitated hydroxides, as described previously27.
SWNTs on the Nafion–Fe(OH)3 layer on PG were dried in vacuo for 18 h. Cyclic 
voltammetry and amperometry were done as previously described.  
 
Atomic force microscopy (AFM) was done with a Nanoscope IV scanning probe 
microscope. Iron heme proteins horse heart myoglobin (Mb, Sigma, >90%) and 
horseradish peroxidase (HRP, Sigma, 250–330 unit mg-1) were attached onto the ends of 
the SWNTs in the forest by using the water-soluble carbodiimide, (1-(3-
(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride, EDC), to promote amide 
linkages between the carboxyl-terminated nanotubes and the lysine residue of the 
 
30 Campbell, J.K.; Sun, L.; Crooks, R.M. J. Am. Chem. Soc., 1999, 121, 3779. 
31 Salvetat, J.P; AJ Kulik, JM Bonard, G Andrew, D Briggs, T Stockli.  J. Adv. Mater. 1999, 11, 54. 
32 Baughman, R. Nanotechnology 2002, 13, 559. 
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proteins. This was done by placing a 20 µL droplet of freshly prepared 24 mM EDC in 
water onto the SWNT forest, immediately followed by adding 30 µL of 3 mg mL-1 Mb 
or HRP. EDC and protein solutions were mixed carefully using a syringe needle, reacted 
for 4 h, then washed extensively with water. 
 
Figure 2-1. Schematics of the fabrication protocol of the vertically aligned SWNT arrays. 
End carboxyl group on the SWNT allow protein bioconjugation facilitating electron 
shuttle to active protein redox sites. 
19 
2.4. Results and Discussion 
 
The SWNT forest construction was optimized using Resonance Raman spectroscopy and 
Atomic force Microscopy (AFM). The Raman spectra gave high intensity bands 
corresponding to graphite- (G-) and defects- (D-) bands respectively. The D-bands 
typically observed between 1250 and 1450 cm-1, originate from the first order scattering 
by in-plane hetero-atom substituents, grain boundaries, vacancies or the other defects and 
by finite size defects33. Raman spectroscopy also shows peaks at 230 cm-1, which is 
characteristic of radial breathing mode (RBM) of SWNT in the Nafion/Fe(OH)3/SWNT 
assembly. This peak is absent in Nafion/Fe(OH)3 confirming successful assembly of the 
SWNT arrays. The pH of the FeCl3 solution was shown to play a key role in the 
successful fabrication of the SWNT forest. Raman spectroscopy shows clearly that the 
optimum pH =1.7 gave 100% SWNT coverage which may be attributed to the formation 
of Fe(OH)3 nanocrystals that acts a precursor for the metal chelation reaction with the 
carboxylated ends of the SWNT.  
 
Figure 2-2 shows AFM images of a SWNT forest on smooth silicon. The width of the 
main features on the SWNT forest surface is about 20 nm, significantly larger than the 
diameter of a single 1 nm diameter SWNT. This is due to the aggregation of SWNT in 
the assembly process and the tip-induced broadening artifact of the AFM34. The height of 
the SWNTs is ~40-60 nm, in agreement with that reported previously35. Cyclic 
voltammograms (CVs) of SWNT forests (Fig. 2(d)) showed an oxidation–reduction peak 
 
33 Dresselhaus, MS, and PC Eklund. Adv. Phys. 2000, 49, 705.  
34 D. Chattopadhyay; S. Lastella; S. Kim; F. Papadimitrakopoulos. J. Am. Chem. Soc. 2002, 124, 223. 
35 Diao, Peng; Liu, Zhongfan; Wu, Bin; Nan, Xiaolin; Zhang, Jin; Wei, Zhong. Chem. Phys. Chem. 02/03,
2002, 898. 
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pair centered at 0.2 V vs. SCE that has been assigned to carboxylate on non-oriented 
SWNT films36.
Figure 2-2. Raman spectra (A) showing characteristic D bands, G band and RBM 
band of SWNT assembled on PG electrodes and the influence of Fe(Cl)3 solution pH 
during SWNT assembly, and (B) AFM image of the resulting vertically aligned 
SWNT arrays on Si wafers at the optimal pH 1.7. 
 
36 Luo, Hongxia; Shi, Zujin; Li, Nanqiang; Gu, Zhennan; Zhuang, Qiankun. Anal. Chem. 2001, 73, 915. 
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Addition of 0.1 mM H2O2 to the buffer resulted in an increase in the peak at -0.8 V, 
possibly due to the direct reduction of peroxide. Cyclic voltammograms of the protein–
SWNT films in buffers showed oxidation–reduction peak pairs near -0.21 V vs. SCE for 
Mb, and -0.25 V for HRP. These potentials are characteristic of the FeIII/FeII redox 
couples of Mb and HRP in thin films37. Furthermore, CV peaks of the SWNTs attributed 
to carboxylate disappeared from the CVs, suggesting that carboxyl groups on the SWNTs 
reacted during protein coupling. Separations between protein reduction and oxidation 
peaks were nearly zero. The peak current of the film increased linearly with increasing 
scan rate. All these results are typical of quasi-reversible voltammetry of a thin surface-
confined layer of redox protein38. Electroactive protein surface concentrations were 
estimated by integrating the CV reduction peaks at low scan rates (25–75 mV s-1). These 
surface concentrations were 0.17 nmol cm-2 for HRP and 0.09 nmol cm-2 for Mb, based 
on PG area (0.2 cm2).  
 
Cyclic voltammogram peaks of the enzymes attached onto SWNT forests were stable, 
and did not decay during repetitive multiple scans. Electrodes could be stored for 
several weeks in buffer at 4º C with only ~20% loss of peak current. This behavior is 
consistent with covalent attachment of the proteins to the carboxylate-bearing ends of 
the SWNTs. On the other hand, when the enzymes were placed onto SWNT forests 
without EDC coupling, CVs persisted for only a few repetitive scans. Additionally, 
when Nafion–Fe(OH)3 under-layers on PG were treated with EDC and enzyme, CV 
peaks observed for Mb and HRP decreased to background levels within 30 min or 
 
37 Zhang, Zhe; Chouchane, Salem; Magliozzo, Richard S.; Rusling, James F. Anal. Chem. 2002, 74, 163. 
38 Rusling, J. F. Electroanalytical Methods for Biological Materials, Marcel Dekker, N.Y. 2002, pp. 195- 
 231. 
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less, suggesting only transient binding of the positively charged proteins to the 
Nafion–Fe(OH)3 under-layer. When Mb or HRP are coupled to an electrode, a 
complex catalytic cycle for the reduction of H2O2 is set up that can be detected via 
catalytic reduction current37,39.
Fig. 2-3 shows a large catalytic reduction peak when H2O2 was added to buffers 
containing the SWNT/enzyme electrodes. Addition of 0.1 mM H2O2 increased the 
peak current 5-fold, and the oxidation peak disappeared. The postulated reaction 
mechanism, (Fig. 2-4.)37,39, features multiple catalytic cycles and 3 possible 
electrochemical reductions. H2O2 converts the FeIII enzyme to a ferryloxy active 
oxidant form. This may be reduced directly at the electrode, but also reacts with H2O2
to give oxygen and regenerate FeIII enzyme. Oxygen can react with the FeII enzyme 
formed at the electrode to give the FeII-O2 enzyme, which can also be reduced. From 
this complex catalytic system, large amperometric signals are generated from HRP 
and/or Mb bound to electrodes poised at -0.3 V vs. SCE. There was a linear increase 
in catalytic reduction peak with increasing H2O2 concentration from 1 to 30 mM. 
Hydrodynamic amperometry provided better sensitivity of the SWNT/enzyme films 
for H2O2 (Fig. 2-5(A)).  
 
The sensitivity to the change in the concentration of H2O2 as the slope of the 
calibration curve below 10 mM was 0:050 mA/mM for SWNT/HRP, 50% better than 
 
39 Munge, Bernard; Estavillo, Carmelita; Schenkman, John B.; Rusling, James F. Chem. Bio. Chem. 2003,
4, 82.  
23 
the sensitivity of SWNT/Mb at 0:040 mA/mM (Fig. 2-5(B)). This is consistent with 
the better peroxidase activity of HRP compared to Mb. The estimated detection limits 
towards H2O2 as three times the noise levels were ~70 nM for SWNT/Mb and ~50 
nM for SWNT/HRP.  
 
Figure 2-3. Cyclic voltammograms at 0.3 Vs-1 for (A) SWNT/Mb and (B) 
SWNT/HRP after injecting 0.1 mM H2O2 (a), SWNT/protein in anaerobic buffer pH 
7.0 (b), SWNT control + 0.1 mM H2O2 (c) and SWNT control in anaerobic buffer pH 
7.0 (d).
24 
 
Figure 2-4. Catalytic mechanism for the peroxide (H2O2) reduction using HRP and/or 
Mb on electrodes resulting in a large amperometric signal. 
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Figure 2-5. Catalytic rotating disk amperometry response at –0.3 V vs. SCE and 
3000 rpm showing stepwise increase in current after injection of 1 mM H2O2 (A) 
of HRP/SWNT and Mb/SWNT, and (B) corresponding calibration curves. Slope 
relates to sensitivity. HRP therefore is more sensitive to redox. 
 
26 
2.5. Conclusions 
 
In summary, we demonstrated the optimal conditions for fabrication of vertically 
aligned SWNT arrays and their application in a biosensor configuration with enzyme 
linked to the ends of the nanotubes. The nanotube forest behaves electrically similar 
to a metal, conducting electrons from the external circuit to the enzymes. The 
preparation of these prototype SWNT-forest biosensors is easy, and enzyme layers 
are stable for weeks. The oriented SWNT forests coupled to antibody-antigen 
biorecognition events have great potential of being fabricated as ultramicroelectrodes 
on the nanometer scale, for ultra-sensitive immunosensor array applications.  
Chapter 3 
 
Immunosensing of PSA using vertically aligned single-walled 
carbon nanotube forests 
3.1 Abstract 
 
3.2. Introduction  
Prostate specific antigen (PSA), a cancer biomarker protein, is produced by normal 
prostate cells. It is essential to fertility and dissolution of seminal fluid40. Clinical 
research has found the protein as an important serum marker for prostate carcinoma. 
While no specific level designates a diagnosis of prostate cancer, PSA serum level 
changes over time are the most valuable way of determining if more diagnostic tests are 
needed40.
40 Brosman, Stanley A. "Prostate Specific Antigen." EMedicine From WebMD. 15 June 2006. University  
 of California Los Angeles Medical School. 23 Mar. 2007 
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Currently a PSA test with a 4.0ng/mL sensitivity levels predicts cancer 67.5-80% of the 
time. Improving sensitivity levels to be able to detect an increase of 0.75ng/mL over a 
year to indicate need of biopsy would possibly prevent  cancers that are missed 20-30% 
of the time40. The most current method of detection comparable to our method is the use 
of optimized ELISA (Enzyme-Linked Immunosorbent Assay)41. This method requires 
somewhere between 50-150WL of serum which proves to be challenging when sampling 
of tissue is necessary.  
 
Our research team following a literature method42 has self-assembled 20-30nm long 
terminally carboxylated single-wall carbon nanotubes (SWNT) into forests standing 
upright on bundles of nafion-iron oxide decorated conductive surfaces. The SWNT 
forests were previously fully characterized using polarized Raman spectroscopy and 
atomic force microscopy which confirmed the vertical orientation of the nanotubes in 
bundles of 20-100nm diameter at cover of >98% of the underlying solid substrate43.
Efficient, direct electrical communication was achieved between the highly conductive 
nanotubes in these forests and peroxidase enzymes bioconjugated to their ends43,44.
In our protocol, primary antibody on the SWNT sensor binds antigen in the sample, 
which in turn, binds a peroxidase-labeled antibody (Figure 3-1). Amperometric signals 
are developed by adding small amounts of hydrogen peroxide to a solution bathing the 
 
41 Ward, A.M.; Catto, J.W.F.; Hamdy, F.C. Ann. Clin. Biochem. 2001, 38, 633-651. 
42 Xhattopadyhyay, D. et al. J. Am. Chem. Soc. 2001, 123,9451-9452. 
43 Yu, Xin.; Kim, Sang Nyon; Papadimitrakopoulous, F.; Rusling, J. F.. Mol. Biosys. 2005, 1, 70-78. 
44 Yu, Xin; Chattopadhyay, D.; Galeska, I; Papadimitrakopoulous; F.; Rusling, J.F. Electrochem. Comm. 
2003, 5, 408-411. 
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sensor to active the peroxidase electrochemical cycle and measuring the current for 
catalytic peroxide reduction while the sensor is under constant voltage44, 45 
 
In this chapter, we report a novel SWNT immunosensors and applications to the detection 
of a cancer biomarker in clinically relevant serum samples. While label-free strategies are 
attractive in that they eliminate the need for antibody labeling, herein we pursue a 
enzyme label strategy that provides advantages of enhanced sensitivity and selectivity, 
the latter by virtue of requiring two specific binding events for detection.6 Decent 
sensitivity was achieved by this non-amplified immunosensor utilizing a bioconjugate 
with 1 or 2 horseradish peroxidase (HRP) labels.  This resulted in a detection limit of 4 
ng mL-1 for prostate specific antigen (PSA) in 10 WL undiluted calf serum.  
 
3.3. Experimental Section 
 
The fabrication of the SWNT forests on graphite tips was discussed in Chapter 2. Primary 
antibody was attached with use of 30WL 400mM EDC [1-(3-(dimethylamino)-propyl)-3-
ethylcarbodiimide hydrochloride] and 100mM NHSS [N-hydroxysulfosuccinimide] 
which was washed off after a 10 minute incubation period. The electrodes were then 
immediately incubated at 37°C for 3 hours (optimal) with 20WL of 330 ng/mL  primary  
 
45 O'Connor, Maire; Kim, Sang Nyon; Killard, Anthony J.; Forster, Robert J.; Smyth, Malcolm R.;  
 Papadimitrakopoulos, Fotios; Rusling, James F. Analyst 2004, 129, 1176-1180. 
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Figure 3-1. Illustration of Sandwich Immunoassay principles for SWNT 
Immunosensors. Initial antibody (Ab1) is bioconjugated to the carboxylated ends of 
the carbon nanotube forests. (Prostate Specific Antigen) PSA is then attached to 
initial antibody. Finally, the HRP labeled secondary antibody (Ab2) is attached to 
PSA allowing for its electrochemical detection. 
 
KE
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anti-PSA antibody (Ab1) in a solution of PBS buffer containing 0.05% Tween-20 at a pH 
of 7. After the incubation period the electrode was washed with the PBS buffer 
containing 0.05% Tween-20. This electrode was then incubated immediately with 20WL
of 2% BSA + 0.05% Tween-20 again followed by washing with PBS buffer and 0.05% 
Tween-20. 
 
The SWNT-Ab1 electrode was then incubated at 37°C for 1hr and 15minutes with 10WL
of PSA-antigen at varying concentrations. This step was again followed by washing with 
PBS buffer containing 0.05% Tween-20. The SWNT-Ab1-PSA electrode was then 
incubated for 1 hr. 15min. at 37°C with 10WL of 4pmol/mL HRP-labeled anti-PSA 
antibody (Ab2-HRP). Again the electrode was washed after incubation with PBS buffer 
containing 0.05% Tween-20. All washing steps were vital as they prevent non-specific 
binding (NSB), which would result in a false-positive amperometric detection of PSA 
antigen.  
 
This working electrode containing the sandwich immunoassay was then placed in a 3-
electrode cell for cyclic voltammetry and amperometry at room temperature. The cell 
contained 10mL of PBS buffer at pH 7 and 1mM of hydroquinone. Electrochemical 
signals were generated with the use of the CHI 660C electrochemical workstation. Cyclic 
voltammetry scans were run on each electrode to prep it for electron exchange in the 
amperometric detection. This provided information on the redox ability of the electrode 
prior to amperommetry. Amperometric detection was then run at -0.3V with the working 
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electrode rotated at 3000rpm. Micromolar injections of 0.4mM H2O2 were used to 
generate the stepwise signal. 
 
3.4. Results and Discussion 
 
Prostate specific antigen (PSA) is a biomarker for prostate carcinoma, and is an 
established clinical tool for diagnosing and monitoring the disease.30 We first analyzed 
undiluted calf serum containing different amounts of PSA with the SWNT 
immunosensors with anti-PSA attached (Figure 3-2). Inhibition of nonspecific binding 
(NSB) was critical to achieve the best sensitivity and detection limits. Thus, we 
developed a highly effective blocking procedure utilizing competitive binding of bovine 
serum albumin (BSA) and the detergent Tween-20, and also optimized the concentration 
of tracer secondary anti-PSA antibody (Ab2-HRP) (see Experimental Section). Before 
exposure to the sample, immunosensors were incubated for 1 h with 20 mL 2% BSA + 
0.05% Tween-20, then washed with 0.05% Tween-20 in buffer. For measurements, 10 
mL undiluted new born calf serum containing PSA was incubated on the inverted sensor 
surface, blocking buffer was used to wash; then the sensor was incubated with 10 mL 
HRP-labeled secondary anti-PSA. The washed immunosensor was then placed into an 
electrochemical cell containing the mediator hydroquinone in buffer, and hydrogen 
peroxide was injected for signal development (Figure 3-2). 
The steady state current increased linearly (Figure 3-3) with PSA concentration over the 
range 0.4-40 ng mL-1, encompassing the 4-10 ng mL-1 prostate cancer prediction range 
for human serum. Excellent device-to-device reproducibility is illustrated by the small 
error bars, and sensitivity of 9.88 nAmL ng -1 (Figure 3-3B) was achieved. The detection 
32 
limit of 0.4 ng mL-1 as the zero PSA control signal plus three-times the control noise level 
(Figure 3-2 inset) was similar to that obtained for PSA in buffers (not shown). Results 
indicate that using BSA and detergent for NSB blocking, and optimizing the 
concentration of Ab2-HRP is very effective to minimize NSB in serum. Control 
experiment, Figure 3-2 inset, represents a SWNT immunosensor taken through the full 
procedure without exposure to PSA, and the response reflects the sum of residual NSB 
and direct reduction of hydrogen peroxide. The controls with no PSA responses were 
significantly smaller than full immunoassay with the lowest PSA concentration, 0.4 
ngmL-1. Results described above with this non-amplified SWNT immunosensors show 
that we can accurately detect cancer biomarkers in complex biological samples with very 
good sensitivity and selectivity (Figures 3-2 and 3-3). Further, the immunosensors have a 
very good reproducibility, as demonstrated by device-to-device standard deviations. 
 
3.5. Summary 
In summary, we have demonstrated a sensitive and selective electrochemical detection of 
a protein cancer biomarker with SWNT immunosensors, as exemplified by the 
measurement of PSA in clinically relevant serum samples. The detection limit of 4 ng 
mL-1 for this non-amplified SWNT immunosensor compares favorably with the standard 
enzyme linked immunosorbent assay (ELISA). This SWNT immunosensors can be 
adapted easily for the detection of other relevant biomarkers and have the potential for 
fabrication into arrays to facilitate multiplexed detection. We believe that such devices 
will evolve toward a very promising future for reliable point-of-care diagnostics of cancer 
and other diseases, and as tools for intra-operation pathological testing, proteomics, and  
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.
Figure 3-2A. Amperometric signal generation for SWNT immunosensors incubated with 
varying concentrations of PSA antigen. Current levels at -0.3V vs. SCE and 3000rpm 
rotation.  
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Figure 3-2B. Amperometric signal generation for SWNT immunosensors at detection 
limits. Current levels at -0.3V vs. SCE and 3000rpm rotation.  
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Figure 3-3. Influence of PSA concentration on amperometric signal. Error bars indicate 
standard deviation of values.  
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systems biology. Work is in progress in our lab to lower the detection limits using signal 
amplification strategies. 
 
Chapter 4 
 
The Pell Scholars Honors Program Connection 
 
4.1 Connection 
The Pell Honors program was created in conjunction with retired United States Senator 
Claiborne DeBorda Pell and Salve Regina University. During Mr. Pell’s Senate career he 
spent 34 years on the Foreign Relations Committee; always true to the founding 
principles of the United Nations in his work. In honor of his life and work the Pell 
Program was formed to create a network of students from different disciplines that would 
focus a portion of their studies on international relations and public policy, placing an 
emphasis on a sense of civic responsibility46. In light of this, my senior thesis focused on 
the electrochemical detection of protein biomarkers, expressly prostate specific antigen, 
for use in the identification of prostate cancer. This technology has the potential for a 
wide range of applications.  Hopefully, with these detection protocols the future costs of 
disease treatment will be lowered as diagnoses of disease will occur much earlier. 
 
With the exception of skin cancer, prostate cancer is the most commonly diagnosed 
cancer in American men and second leading cause of cancer deaths. 20% of men will 
develop prostate cancer that is invasive before death. Currently digital rectal exams 
 
46 "The Pell Scholars Honors Program." The Pell Center for International Relations and Public Policy.
2007. Salve Regina University. 10 Mar. 2007<http://www.salve.edu/pellcenter/scholars.cfm#overview>. 
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(DREs) in conjunction with tests for the protein serum marker Prostate Specific Antigen 
(PSA) are the methods employed in diagnoses of this disease47.
The cost of treatment for such a devastating disease can be very high. The cost by 
definition encompasses physician and healthcare professionals, care provided by 
hospitals, drugs, and laboratory services48. Many studies have been conducted to 
determine the cost-benefit of early cancer detection. Figure 4-1 and Figure 4-2 describe 
the benefit-cost equation and its variables as determined by the Cancer Journal for 
Clinicians.
The data provided by the Cancer Journal for Clinicians indicates at current a negative 
benefit-cost of screening for individuals as the current cost of testing outweighs the 
benefits mathematically. The current data of this study indicates that early detection 
could be more economical through a more specific PSA assay49. A population that is 
growing older also indicates a higher incidence of disease in the future50.
47 Ferrini, Rebecca, and Steven Woolf. "Screening for Prostate Cancer in American Men." American 
College of Preventive Medicine. 10 Mar. 2007 <http://www.acpm.org/prostate.htm>. 
48 Grover, Steven, Hanna Zowall, Louis Coupal, and Murray Krahn. CMAJ: Canadian Medical Association  
 Journal, 1999, 160. 
49 Littrup, P.J.; Goodman, A.C.; Mettlin, C.J.; CA: Cancer J Clin, 1993, 43, 134-149. 
50 Norlund, A.; Alvegard, T.; Lithman, T.; Merlo, J.; Noreen, D.; Scand J Urol Nephrol, 2003, 37, 371-375. 
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V=pnwB + (1-p)cR - S - [pn+ (1-p)(1-c)]w(T+A) - (1-p)(1-c)F 
 
Dollar Values  
V Net benefit per individual screened 
B Value of benefits from early detection and treatment 
R Value of reassurance from a negative test 
S Cost of screening test, procedure, or scenario 
T Costs of staging and treatment received as a result of screening 
A
Cost of adverse effects of screening tests and subsequent follow-up tests and morbidities 
of therapy 
F Potential psychic cost of false-positive results 
Probabilities  
p Prevalence of prostate cancer (fraction of patients who demonstrate cancer during 
screening sequence, as well as from interval detection) 
n
Sensitivity (probability of a positive results when clinically detectable cancer is present) 
c Specificity (probability of a negative result when no cancer is evident from the screening 
test or sequence) 
w Probability of a patient returning for therapy and/or having a cancer stage or medical 
condition appropriate for therapy 
Figure 4-1. Benefit-cost equation of prostate cancer screening with definition of 
variables49.
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Figure 4-2. Benefit-cost equation of prostate cancer screening variable values49.
This indicates a need for a better method of PSA detection that would be available at a 
lower cost which would make screening accessible to a larger portion of the population. 
Our current research is looking to create an effective sensitive and cost effective method 
for PSA analysis leading to earlier and more accurate detection. In the future, not only 
will PSA be detected for but also multiple biomarkers proteins including PF4 and MMP2 
that are currently under investigations in our lab.  As a result of this technology, 
hopefully a dramatic decrease in prostate cancer deaths will occur.  
 
Acknowledgements 
First and foremost I would like to thank Dr. Bernard Munge for the opportunity to be a 
part of this remarkable project. The lessons I have learned not only about my topic but 
about the research process itself will prove to be invaluable in my future endeavors. 
Parameter Values for Benefit-Cost Analysis 
B R A T A F p n c q V
DRE (highly skilled 
examiner) $29,443 $90 $90 $20,000 $1,391 $1,391 0.053 0.606 0.963 0.85 -$474 
DRE (generalized) $29,443 $90 $90 $20,000 $1,391 $1,391 0.053 0.484 0.77 0.85 -$4,112 
DRE + PSA 2ng/mL $29,443 $180 $180 $20,000 $1,470 $1,470 0.053 0.96 0.688 0.85 -$5,544 
DRE + PSA 3ng/mL $29,443 $180 $180 $20,000 $1,438 $1,438 0.053 0.899 0.827 0.85 -$2,936 
DRE + PSA 4ng/mL $29,443 $180 $180 $20,000 $1,421 $1,421 0.053 0.869 0.896 0.85 -$1,645 
PSA 2ng/mL $29,443 $90 $90 $20,000 $1,477 $1,477 0.053 0.909 0.705 0.85 -$5,126 
PSA 3ng/mL $29,443 $90 $90 $20,000 $1,436 $1,436 0.053 778 0.853 0.85 -$2,473 
PSA 4ng/mL $29,443 $90 $90 $20,000 $1,413 $1,413 0.053 0.667 0.927 0.85 -$1,126 
Mammography 
 
$29,443 
 
$50 
 
$50 
 
$20,000 
 
$1,450 
 
$1,450 
 
0.005 
 
0.8 
 
0.97 
 
0.99 
 
-$562 
 
40 
 
Thank you to Dr. Stephen Trainor and Dr. Paula Martasian for your advice and 
supervision throughout my experience with Pell Program. 
 
Also thank you to Dr. Sandor Kadar for four years of continual guidance.  
 
This project would not have been possible without the incredible help of my colleagues 
Jaqueline Fisher, Phelipe Hurt, Andrew Hall, Colleen Krause, and Lines Millord.
Finally, I wish to acknowledge the financial support from the National Center for 
Research Resource, a component of the National Institute of Health (NCRR/NIH) 
 
LIST OF FIGURES 
Figure 1-1. Prostate Specific Antigen structure as determined by x-ray………….….12 
diffraction 
 
Figure 1-2.  Two types of carbon nanotubes; SWNT & MWNT…………….……….13 
 
Figure 1-3.      Heme group of Horseradish Peroxidase...………………………………..15 
 
Figure 2-1.  Schematics of the fabrication protocol of the vertically…………………20  
aligned SWNT arrays. End carboxyl group on the SWNT 
allow protein bioconjugation facilitating electron shuttle 
to active protein redox sites. 
 
Figure 2-2.  Raman spectra (A) showing characteristic D bands,……………………22 
G band and RBM band of SWNT assembled on PG 
electrodes and the influence of Fe(Cl)3 solution  
pH during SWNT assembly, and (B) AFM image 
of the resulting vertically aligned SWNT arrays on 
Si wafers at the optimal pH 1.7. 
 
41 
Figure 2-3.  Cyclic voltammograms at 0.3 Vs-1 for (A) SWNT/Mb………………….25 
and (B) SWNT/HRP after injecting 0.1 mM H2O2 (a), 
SWNT/protein in anaerobic buffer pH 7.0 (b), SWNT 
control + 0.1 mM H2O2 (c) and SWNT control in anaerobic 
buffer pH 7.0 (d) 
Figure 2-4.  Catalytic mechanism for the peroxide (H2O2) reduction……………….. 26 
using HRP and/or Mb on electrodes resulting in a  
large amperometric signal. 
 
Figure 2-5.  Catalytic rotating disk amperometry response at…………………..…….27 
–0.3 V vs. SCE and 3000 rpm showing stepwise  
increase in current after injection of 1 mM H2O2 
(A) of HRP/SWNT and Mb/SWNT, and (B)  
corresponding calibration curves.
Figure 3-1.  Illustration of Sandwich Immunoassay principles……………….………33 
for SWNT Immunosensors. 
 
Figure 3-2A.  Amperometric signal generation for SWNT……………………….…….37 
immunosensors incubated with varying concentrations 
of PSA antigen. Current levels at -0.3V and 
3000rpm rotation. 
 
Figure 3-2B.   Amperometric signal generation for SWNT immunosensors……..……..38 
at detection limits. Current levels at -0.3V vs. SCE and  
3000rpm rotation.  
42 
 
Figure 3-3.  Influence of PSA concentration on amperometric signal…………..……39  
Error bars indicate standard deviation of values.  
 
Figure 4-1.  Benefit-cost equation of prostate cancer screening with………..……….44 
definition of variables. 
 
Figure 4-2.  Benefit-cost equation of prostate cancer screening……………...………45 
variable values.  
 
43 
 
44 
 
